Aurobindo, Glenmark, and Zydus are recalling pharmaceutical products in the US due to manufacturing issues. Aurobindo and Glenmark's recalls involve excessive impurities, while Zydus's recall is due to a labeling error. The recalls affect over 200,000 bottles/packs of various medications, including Cinacalcet, Diltiazem, and Esomeprazole.
